Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
25,474,542
-
Share change
-
-3,866,864
-
Total reported value
-
$136,035,080
-
Put/Call ratio
-
129%
-
Price per share
-
$5.34
-
Number of holders
-
68
-
Value change
-
-$23,251,716
-
Number of buys
-
27
-
Number of sells
-
26
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2019
As of 30 Sep 2019,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,474,542 shares.
The largest 10 holders included
NEA Management Company, LLC, ORBIMED ADVISORS LLC, Polar Capital LLP, Consonance Capital Management LP, GOLDMAN SACHS GROUP INC, FRANKLIN RESOURCES INC, FMR LLC, BlackRock Inc., ACUTA CAPITAL PARTNERS, LLC, and HealthCor Management, L.P..
This page lists
68
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.